Aziz Nazha, Carlos G. Romo, Hagop Kantarjian and Jorge Cortes (2013) “The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia”, Haematologica. Pavia, Italy, 98(10), pp. e131-e131. doi: 10.3324/haematol.2013.091678.